Pacjenci
Czym jest alergia?
Alergia na roztocza kurzu domowego
Alergia na pyłki
Życie z alergią
Skutki społeczno-ekonomiczne
Czym jest astma alergiczna?
Jak diagnozuje się alergię?
Leczenie alergii
Pracownicy ochrony zdrowia
Leczenie alergii i astmy
Produkty
Reakcje niepożądane
Rozpoczęcie leczenia
Program badań klinicznych
Prace badawczo-rozwojowe
Zrozumieć immunoterapię
Plan prac badawczo-rozwojowych
Badania naukowe
Kariera
Praca w firmie ALK
Wolne stanowiska
O firmie ALK
ALK w skrócie
Produkcja
Obecność na całym świecie
Organizacja
Historia
Wartości
Właściciele
Media
ALK GBSC
About Us
News
Careers
Contact
Zgłaszanie działań niepożądanych
Fulltext search
Search
Annual General Meeting in ALK-Abelló A/S held on 13 March 2025
Read more
about Annual General Meeting in ALK-Abelló A/S held on 13 March 2025
Link
https://www.globenewswire.com/news-release/2025/03/13/3042490/0/en/Annual-Gener…
Created date
Thu, 03/13/2025 - 12:00
Nasdaq ID
3042490
Last updated:
2025.03.13
ACARIZAX® approved in Canada for treatment of young children
Read more
about ACARIZAX® approved in Canada for treatment of young children
Link
https://www.globenewswire.com/news-release/2025/03/07/3038942/0/en/ACARIZAX-app…
Created date
Fri, 03/07/2025 - 12:00
Nasdaq ID
3038942
Last updated:
2025.03.07
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Read more
about Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Link
https://www.globenewswire.com/news-release/2025/03/04/3036986/0/en/Report-on-tr…
Created date
Tue, 03/04/2025 - 12:00
Nasdaq ID
3036986
Last updated:
2025.03.04
FDA approves ODACTRA® for the treatment of house dust mite allergy in young children
Read more
about FDA approves ODACTRA® for the treatment of house dust mite allergy in young children
Link
https://www.globenewswire.com/news-release/2025/02/27/3034245/0/en/FDA-approves…
Created date
Thu, 02/27/2025 - 12:00
Nasdaq ID
3034245
Last updated:
2025.02.27
Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025
Read more
about Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025
Link
https://www.globenewswire.com/news-release/2025/02/12/3025225/0/en/Invitation-t…
Created date
Wed, 02/12/2025 - 12:00
Nasdaq ID
3025225
Last updated:
2025.02.12
ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system
Read more
about ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system
Link
https://www.globenewswire.com/news-release/2025/01/30/3017756/0/en/ALK-s-house-…
Created date
Thu, 01/30/2025 - 12:00
Nasdaq ID
3017756
Last updated:
2025.01.30
ALK – Financial calendar for the 2025 financial year
Read more
about ALK – Financial calendar for the 2025 financial year
Link
https://www.globenewswire.com/news-release/2024/12/20/3000728/0/en/ALK-Financia…
Created date
Fri, 12/20/2024 - 12:00
Nasdaq ID
3000728
Last updated:
2024.12.20
Positive results advance peanut tablet to phase II development
Read more
about Positive results advance peanut tablet to phase II development
Link
https://www.globenewswire.com/news-release/2024/12/18/2998913/0/en/Positive-res…
Created date
Wed, 12/18/2024 - 12:00
Nasdaq ID
2998913
Last updated:
2024.12.18
ALK Christmas Party
GO BACK TO NEWS
Last updated:
2024.12.17
ALK Halloween 2024
GO BACK TO NEWS
Last updated:
2024.10.31
Pagination
First page
« First
Previous page
‹ Previous
…
Page
2
Page
3
Page
4
Page
5
Current page
6
Page
7
Page
8
Page
9
Page
10
…
Next page
Next ›
Last page
Last »
Subscribe to